Granules India 将来の成長

NSEI:GRANULES - アナリストの将来予測と過去の財務データ ( )INR Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
3/31/2027	62,201	8,128	2,444	8,144	6
3/31/2026	54,814	6,738	2,139	7,497	8
3/31/2025	46,633	4,914	2,288	8,728	6
9/30/2024	44,778	4,872	3,392	8,198	N/A
6/30/2024	47,007	4,921	N/A	N/A	N/A
3/31/2024	45,064	4,053	588	4,394	N/A
12/31/2023	45,261	3,953	N/A	N/A	N/A
9/30/2023	45,166	3,939	-346	3,769	N/A
6/30/2023	44,779	4,369	N/A	N/A	N/A
3/31/2023	45,119	5,166	3,281	7,387	N/A
12/31/2022	43,464	5,080	N/A	N/A	N/A
9/30/2022	41,970	4,845	1,545	4,970	N/A
6/30/2022	39,346	4,201	N/A	N/A	N/A
3/31/2022	37,649	4,128	-657	3,321	N/A
12/31/2021	35,343	4,293	N/A	N/A	N/A
9/30/2021	33,820	4,753	735	4,714	N/A
6/30/2021	33,518	5,582	N/A	N/A	N/A
3/31/2021	32,375	5,495	1,611	4,325	N/A
12/31/2020	30,381	5,142	N/A	N/A	N/A
9/30/2020	28,976	4,314	2,723	4,459	N/A
6/30/2020	27,390	3,636	N/A	N/A	N/A
3/31/2020	25,986	3,354	2,917	4,762	N/A
12/31/2019	26,121	3,071	N/A	N/A	N/A
9/30/2019	25,399	3,034	1,551	3,714	N/A
6/30/2019	24,212	2,679	N/A	N/A	N/A
3/31/2019	22,792	2,364	-172	2,622	N/A
12/31/2018	21,697	1,928	N/A	N/A	N/A
9/30/2018	19,487	1,675	N/A	N/A	N/A
6/30/2018	17,603	1,476	N/A	N/A	N/A
3/31/2018	16,846	1,326	N/A	-7	N/A
12/31/2017	15,361	1,578	N/A	N/A	N/A
9/30/2017	14,785	1,619	N/A	N/A	N/A
6/30/2017	14,456	1,624	N/A	N/A	N/A
3/31/2017	14,106	1,645	N/A	1,882	N/A
12/31/2016	14,971	1,473	N/A	N/A	N/A
9/30/2016	14,626	1,374	N/A	N/A	N/A
6/30/2016	14,524	1,289	N/A	N/A	N/A
3/31/2016	13,572	1,230	N/A	1,514	N/A
12/31/2015	14,147	1,077	N/A	N/A	N/A
9/30/2015	13,895	1,041	N/A	N/A	N/A
6/30/2015	13,307	952	N/A	N/A	N/A
3/31/2015	12,937	909	N/A	1,503	N/A
12/31/2014	12,573	921	N/A	N/A	N/A
9/30/2014	12,217	904	N/A	N/A	N/A
6/30/2014	11,786	834	N/A	N/A	N/A
3/31/2014	10,973	752	N/A	1,079	N/A
12/31/2013	9,837	640	N/A	N/A	N/A

アナリストによる今後の成長予測

収入対貯蓄率: GRANULESの予測収益成長率 (年間22.1% ) は貯蓄率 ( 6.7% ) を上回っています。

収益対市場: GRANULESの収益 ( 22.1% ) はIndian市場 ( 18.1% ) よりも速いペースで成長すると予測されています。

高成長収益: GRANULESの収益は今後 3 年間で大幅に増加すると予想されています。

収益対市場: GRANULESの収益 ( 13.7% ) Indian市場 ( 10.6% ) よりも速いペースで成長すると予測されています。

高い収益成長: GRANULESの収益 ( 13.7% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: GRANULESの自己資本利益率は、3年後には低くなると予測されています ( 16.2 %)。

Granules India 将来の成長

Future 基準チェック /46

主要情報

今後の成長に関する最新情報

Granules India Limited (NSE:GRANULES) Analysts Are Pretty Bullish On The Stock After Recent Results

Price target increased by 25% to ₹610

Granules India Limited Just Missed Revenue By 6.4%: Here's What Analysts Think Will Happen Next

Price target increased by 8.1% to ₹375

Price target increased to ₹338

Price target decreased to ₹319

Recent updates

Second quarter 2025 earnings released: EPS: ₹4.01 (vs ₹4.22 in 2Q 2024)

Granules India Limited to Report Q2, 2025 Results on Nov 06, 2024

Granules India Limited Announces Executive Changes

Is Granules India (NSE:GRANULES) Using Too Much Debt?

Investor sentiment deteriorates as stock falls 19%

Granules India Limited Receives ANDA Approval for Glycopyrrolate Oral Solution Registered Office

Granules India Limited Approves Final Dividend for the Fiscal Year 2023-24

Granules India Limited (NSE:GRANULES) Analysts Are Pretty Bullish On The Stock After Recent Results

Price target increased by 25% to ₹610

Granules India Limited (NSE:GRANULES) Stock Rockets 27% But Many Are Still Ignoring The Company

Granules India Limited's (NSE:GRANULES) CEO Compensation Is Looking A Bit Stretched At The Moment

Upcoming dividend of ₹1.50 per share

Full year 2024 earnings: EPS and revenues miss analyst expectations

Granules India's (NSE:GRANULES) Dividend Will Be ₹1.50

Granules India Limited to Report Q1, 2025 Results on Jul 30, 2024

Granules India's (NSE:GRANULES) Dividend Will Be ₹1.50

Investor sentiment improves as stock rises 15%

Dividend of ₹1.50 announced

Granules India Limited, Annual General Meeting, Aug 06, 2024

Full year 2024 earnings: EPS and revenues miss analyst expectations

Granules India Limited Recommends Final Dividend for the Financial Year 2023-24, Payable on July 30, 2024

Granules India Limited to Report Q4, 2024 Results on May 15, 2024

High number of new directors

Investors Holding Back On Granules India Limited (NSE:GRANULES)

Granules India Limited Appoints Atul Dhavle as Chief Human Resources Officer

Granules India Limited Announces That J. Shravan Reddy Shall Cease to Be Senior Vice President & Head- API Manufacturing

Granules India Limited Just Missed Revenue By 6.4%: Here's What Analysts Think Will Happen Next

Third quarter 2024 earnings released: EPS: ₹5.18 (vs ₹5.11 in 3Q 2023)

Granules India Limited to Report Q3, 2024 Results on Jan 23, 2024

Many Still Looking Away From Granules India Limited (NSE:GRANULES)

Granules India Limited Receives ANDA Approval for Pantoprazole Sodium Delayed-Release Tablets

Granules India (NSE:GRANULES) Has A Pretty Healthy Balance Sheet

Price target increased by 8.1% to ₹375

Second quarter 2024 earnings released: EPS: ₹4.22 (vs ₹5.85 in 2Q 2023)

Granules India Limited to Report Q2, 2024 Results on Nov 09, 2023

A Look At The Fair Value Of Granules India Limited (NSE:GRANULES)

Granules India Limited Receives ANDA Approval for Esomeprazole Magnesium Delayed-Release Capsules

Granules India Limited Approves Final Dividend for the Fy 2022-23

Granules India Limited Receives US FDA Approval for the ANDA Files for Metoprolol Succinate ER Tablets Registered Office

Granules India Limited to Report Q1, 2024 Results on Aug 09, 2023

Upcoming dividend of ₹1.50 per share at 0.5% yield

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Granules India Limited Announces Approval for the Store Brand OTC Equivalent of Advil®? Dual Action Tablets Registered Office

Granules India Limited Receives ANDA Approval for Venlafaxine ER Capsules

Does Granules India (NSE:GRANULES) Have A Healthy Balance Sheet?

Granules India Limited, Annual General Meeting, Aug 10, 2023

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Should You Be Adding Granules India (NSE:GRANULES) To Your Watchlist Today?

Third quarter 2023 earnings: EPS misses analyst expectations

Granules India (NSE:GRANULES) Has A Pretty Healthy Balance Sheet

Granules India Limited to Report Q3, 2023 Results on Jan 24, 2023

Granules India Limited Announces Resignation of Sandip Neogi as Chief Financial Officer (Cfo)

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Granules India Limited to Report Q2, 2023 Results on Oct 20, 2022

Does Granules India (NSE:GRANULES) Have A Healthy Balance Sheet?

Granules India Limited Receives Approval for Abbreviated New Drug Application from US Food & Drug Administration

Estimating The Intrinsic Value Of Granules India Limited (NSE:GRANULES)

Price target increased to ₹338

Granules India Limited (BSE:532482) announces an Equity Buyback for 6,250,000 shares, representing 2.52% for INR 2,500 million.

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Granules India Limited to Report Q1, 2023 Results on Aug 09, 2022

Granules India Limited Approves Final Dividend for the Financial Year 2021-22

Granules India (NSE:GRANULES) Is Due To Pay A Dividend Of ₹0.75

Upcoming dividend of ₹0.75 per share

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Investor sentiment improved over the past week

Is Granules India (NSE:GRANULES) A Risky Investment?

Now 21% undervalued after recent price drop

Price target decreased to ₹319